Caris Life Sciences (CAI) Net Margin (2024 - 2026)

Caris Life Sciences' Net Margin history runs 3 years deep, the most recent figure standing at 0.24% for Q1 2026.

• In Q1 2026, Net Margin rose 10483.0% year-over-year to 0.24%; the TTM figure through Mar 2026 stood at 45.35% (up 3668.0% YoY), while the FY2025 annual figure was 66.25%, up 2550.0% from the prior year.
• Net Margin was 0.24% for Q1 2026 at Caris Life Sciences, down from 27.98% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 27.98% in Q4 2025 to a low of 285.12% in Q2 2025.
• Historically, Net Margin has averaged 72.44% across 3 years, with a median of 68.71% in 2024.
• The sharpest annual moves came in 2025 and 2026: Net Margin slumped 19538 bps in 2025, then soared 10483 bps in 2026.
• A 3-year view of Net Margin shows it stood at 47.68% in 2024, then soared by 159 bps to 27.98% in 2025, then tumbled by 101 bps to 0.24% in 2026.
• The last three Net Margin figures came in at 0.24% (Q1 2026), 27.98% (Q4 2025), and 11.22% (Q3 2025), per Business Quant data.